Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abbott Laboratories 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 USA

www.abbott.com Employees: 114,000 P: 224-667-6100

Sector:

Medical

Description:

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Key Statistics

Overview:

Market Capitalization, $K 217,080,768
Enterprise Value, $K 223,589,760
Shares Outstanding, K 1,738,872
Annual Sales, $ 41,950 M
Annual Net Income, $ 13,402 M
Last Quarter Sales, $ 11,369 M
Last Quarter Net Income, $ 1,644 M
EBIT, $ 9,438 M
EBITDA, $ 12,656 M
60-Month Beta 0.72
% of Insider Shareholders 0.46%
% of Institutional Shareholders 75.18%
Float, K 1,730,873
% Float 99.54%
Short Interest 15,876
Short Float 0.91%
Short Volume Ratio 0.58

Growth:

1-Year Return 8.30%
3-Year Return 13.71%
5-Year Return 14.02%
5-Year Revenue Growth 31.49%
5-Year Earnings Growth 44.14%
5-Year Dividend Growth 71.88%

Per-Share Information:

Most Recent Earnings 1.30 on 10/15/25
Next Earnings Date 01/28/26
Earnings Per Share ttm 4.99
EPS Growth vs. Prev Qtr 3.17%
EPS Growth vs. Prev Year 7.44%
Annual Dividend & Yield 2.36 (1.89%)
Annual Dividend & Yield (Fwd) 2.36 (1.89%)
Most Recent Dividend 0.590 on 10/15/25
Next Ex-Dividends Date 01/15/26
Dividend Payable Date 02/13/26
Dividend Payout Ratio 46.05%
Most Recent Split 2-1 on 01/02/13

ABT Ratios

Ratio
Price/Earnings ttm 25.01
Price/Earnings forward 24.24
Price/Earnings to Growth 2.27
Return-on-Equity % 17.60%
Return-on-Assets % 10.58%
Profit Margin % 31.95%
Debt/Equity 0.25
Price/Sales 5.17
Price/Cash Flow 18.96
Price/Book 4.23
Book Value/Share 29.48
Interest Coverage 13.55

ABT Dividends

Date Value
01/11/24 $0.5500
04/12/24 $0.5500
07/15/24 $0.5500
10/15/24 $0.5500
01/15/25 $0.5900
04/15/25 $0.5900
07/15/25 $0.5900
10/15/25 $0.5900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar